Antares Pharma, Inc. AIS today reported financial and operating results for the fourth quarter ended December 31, 2010.
Total revenue was $3.3 million and $12.8 million for the three months and year ended December 31, 2010
Net loss per share decreased to $0.02 for the fourth quarter of 2010 from $0.03 in 2009.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in